Super-Resolution Microscopy Analysis of Hepatitis B Viral cccDNA and Host Factors

Viruses. 2023 May 16;15(5):1178. doi: 10.3390/v15051178.

Abstract

Infection with hepatitis B virus (HBV) cannot be cured completely because of the persistence of covalently closed circular DNA (cccDNA). We previously found that the host gene dedicator of cytokinesis 11 (DOCK11) was required for HBV persistence. In this study, we further investigated the mechanism that links DOCK11 to other host genes in the regulation of cccDNA transcription. cccDNA levels were determined by quantitative real-time polymerase chain reaction (qPCR) and fluorescence in situ hybridization (FISH) in stable HBV-producing cell lines and HBV-infected PXB-cells®. Interactions between DOCK11 and other host genes were identified by super-resolution microscopy, immunoblotting, and chromatin immunoprecipitation. FISH facilitated the subcellular localization of key HBV nucleic acids. Interestingly, although DOCK11 partially colocalized with histone proteins, such as H3K4me3 and H3K27me3, and nonhistone proteins, such as RNA Pol II, it played limited roles in histone modification and RNA transcription. DOCK11 was functionally involved in regulating the subnuclear distribution of host factors and/or cccDNA, resulting in an increase in cccDNA closely located to H3K4me3 and RNA Pol II for activating cccDNA transcription. Thus, it was suggested that the association of cccDNA-bound Pol II and H3K4me3 required the assistance of DOCK11. DOCK11 facilitated the association of cccDNA with H3K4me3 and RNA Pol II.

Keywords: H3K4me3; HBV; RNA Pol II; fluorescence in in situ hybridization FISH; transcription factors.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • DNA, Circular / genetics
  • DNA, Circular / metabolism
  • DNA, Viral / genetics
  • DNA, Viral / metabolism
  • Hepatitis B virus / physiology
  • Hepatitis B* / genetics
  • Hepatitis B, Chronic*
  • Humans
  • In Situ Hybridization, Fluorescence
  • Microscopy
  • RNA Polymerase II / genetics
  • RNA Polymerase II / metabolism
  • Virus Replication / genetics

Substances

  • RNA Polymerase II
  • DNA, Viral
  • DNA, Circular

Grants and funding

This research was supported by Advanced Research and Development Programs for Medical Innovation (grant number JP22fk0310514).